← FDA DRUG APPROVALS

FDA ANDA · ANDA062238

DYCILL

Sponsor: GLAXOSMITHKLINE

APPLICATION
ANDA062238
TYPE
ANDA
ORIGINAL APPROVAL
1979-12-31
LATEST ACTION
1998-04-20
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

DYCILLDiscontinued
DICLOXACILLIN SODIUM EQ 500MG BASE · CAPSULE · ORAL
DYCILLDiscontinued
DICLOXACILLIN SODIUM EQ 250MG BASE · CAPSULE · ORAL

Approval history

1998-04-20Manufacturing (CMC) · Supplement 2AP
1996-08-06Labeling · Supplement 1AP
1979-12-31OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →